Search results for: 'denali+captura+scienc+221b'
- Did you mean
- deals captura scienc 2016
-
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Metabolic Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More -
Gynecology Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Gynecology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the world's leading biopharma companies
Learn More -
Antibody Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Bioinformatics Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Bioinformatics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
